Jacobs Levy Equity Management
HRMY icon

Jacobs Levy Equity Management’s Harmony Biosciences HRMY Stock Holding History

Jacobs Levy Equity Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.17M Buy
141,968
+59,700
+73% +$1.88M 0.02% 425
2026
Q1 		$2.3M Hold
82,268
– – 0.01% 560
2025
Q4 		$3.08M Sell
82,268
-157,504
-66% -$5.18M 0.01% 510
2025
Q3 		$6.61M Sell
239,772
-21,854
-8% -$753K 0.03% 368
2025
Q2 		$8.27M Sell
261,626
-39,098
-13% -$1.26M 0.03% 337
2025
Q1 		$9.98M Sell
300,724
-12,289
-4% -$441K 0.04% 339
2024
Q4 		$10.8M Buy
313,013
+88,532
+39% +$3.04M 0.04% 293
2024
Q3 		$8.98M Sell
224,481
-20,845
-8% -$732K 0.03% 341
2024
Q2 		$7.4M Buy
245,326
+7,999
+3% +$241K 0.03% 381
2024
Q1 		$7.97M Sell
237,327
-1,408
-0.6% -$45.2K 0.04% 338
2023
Q4 		$7.71M Buy
238,735
+3,847
+2% +$107K 0.04% 345
2023
Q3 		$7.7M Sell
234,888
-51,136
-18% -$1.78M 0.05% 299
2023
Q2 		$10.1M Sell
286,024
-90,362
-24% -$3.12M 0.06% 279
2023
Q1 		$12.3M Sell
376,386
-2,641
-0.7% -$120K 0.08% 256
2022
Q4 		$20.9M Sell
379,027
-42,138
-10% -$2.32M 0.14% 185
2022
Q3 		$18.7M Buy
+421,165
New +$20.5M 0.15% 177

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's HRMY Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Harmony Biosciences (HRMY) stake by 73% in Q2 2026, buying an estimated $1.88M and bringing the position to 141,968 shares worth $5.17M. The position accounts for 0.02% of the portfolio, ranked #425.

Jacobs Levy Equity Management first reported a position in HRMY in Q3 2022 and has held it in 16 quarters since. The position peaked at $20.9M in Q4 2022. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Jacobs Levy Equity Management held 141,968 shares of Harmony Biosciences worth $5.17M as of Q2 2026.
  • Jacobs Levy Equity Management bought 59,700 Harmony Biosciences shares in Q2 2026, an estimated $1.88M.
  • Harmony Biosciences made up 0.02% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #425 holding.
  • Jacobs Levy Equity Management first reported a position in Harmony Biosciences in Q3 2022 and has held it in 16 quarters since.
  • Jacobs Levy Equity Management's Harmony Biosciences position peaked at $20.9M in Q4 2022.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.